go back

FLT3 Duplication Amount In Leukemia

Rhode Island rates for HCPCS 0046U

Used in acute myeloid leukemia to assess a duplication inside the FLT3 gene, a change that affects how the disease behaves. Rather than only reporting whether the duplication is there, it measures how much duplicated sequence is present.

Rates data updated July 2026.

Facilitymedian $490 · 10th–90th $427$7410%20%40%10th90th$490Professionalmedian $115 · 10th–90th $115$1660%50%90th$115$100.0$200.0$500.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$478.63
Median
$741.31
Typical High
$741.31
Aetna
Setting
Professional
Modifier
Global
Typical Low
$114.82
Median
$114.82
Typical High
$123.03
BCBS
Setting
Facility
Modifier
Global
Typical Low
$426.58
Median
$467.74
Typical High
$524.81
BCBS
Setting
Professional
Modifier
Global
Typical Low
$537.03
Median
$537.03
Typical High
$537.03
Cigna
Setting
Facility
Modifier
Global
Typical Low
$457.09
Median
$457.09
Typical High
$457.09
Cigna
Setting
Professional
Modifier
Global
Typical Low
$97.72
Median
$97.72
Typical High
$97.72
United
Setting
Facility
Modifier
Global
Typical Low
$234.42
Median
$489.78
Typical High
$489.78
United
Setting
Professional
Modifier
Global
Typical Low
$83.18
Median
$165.96
Typical High
$407.38